Kymera Therapeutics (NASDAQ:KYMR) is preparing to release its quarterly earnings on Thursday, 2024-10-31. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Kymera Therapeutics to report an earnings per share (EPS) of $-0.84. The announcement from Kymera Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Performance in Previous EarningsIn the previous earnings r…